Lisinopril+Torasemide
Toralis tablets contain two active substances - lisinopril and torasemide, which help control high blood pressure and symptoms of heart failure, such as swelling caused by fluid accumulation in the body.
Lisinopril belongs to a group of medicines called angiotensin-converting enzyme inhibitors, which prevent the production of a substance that increases blood pressure, resulting in the dilation of blood vessels and making it easier for the heart to pump blood to all parts of the body.
Torasemide belongs to a group of loop diuretics, which increase the amount of water excreted in the urine, reducing the amount of fluid in the blood vessels.
Toralis, which contains lisinopril and torasemide in one tablet, is used in patients who have previously taken lisinopril and torasemide in the same doses as in Toralis, but in separate tablets (Toralis is used instead of these tablets). This reduces the number of tablets taken by the patient.
Toralis can be used in patients:
Before starting to take Toralis, discuss with your doctor or pharmacist:
In black patients, angioedema may occur more frequently; additionally, lisinopril may be less effective in lowering blood pressure.
Your doctor may recommend regular monitoring of kidney function, blood pressure, electrolyte levels (e.g., potassium, sodium), blood count, and glucose and lipid levels in the blood.
Torasemide may cause positive results in doping tests.
Toralis is not recommended for use in children and adolescents.
Tell your doctor or pharmacist about all the medicines you are taking, have recently taken, or might take.
Your doctor may recommend a dose change and/or take other precautions. In some cases, it may be necessary to stop one of the medicines.
This is especially true for the following medicines: aliskiren, angiotensin II receptor antagonists, potassium supplements, potassium-sparing diuretics, potassium-containing salt substitutes, and other medicines that may increase potassium levels in the blood (such as heparin and cotrimoxazole, a combination of trimethoprim and sulfamethoxazole), lithium, aminoglycoside antibiotics, or cefalosporins.
Caution should be exercised when using:
Toralis can be taken with or without food.
Excessive sodium intake may weaken the effect of the medicine.
If you have any doubts about the amount of alcohol allowed while taking Toralis, consult your doctor, as blood pressure-lowering medicines and alcohol may enhance each other's effects.
If you are pregnant, think you may be pregnant, or plan to have a baby, consult your doctor or pharmacist before taking this medicine.
Your doctor will usually recommend stopping Toralis treatment before planned pregnancy or as soon as pregnancy is confirmed and recommend taking a different medicine instead of Toralis. Women of childbearing age who do not plan to become pregnant should use effective contraception.
Inform your doctor about breastfeeding or intending to breastfeed. Do not take Toralis while breastfeeding. Your doctor will recommend a different medicine if you want to breastfeed.
This medicine may occasionally cause dizziness, blurred vision, or even fainting, especially at the beginning of treatment, when changing the dose, or in combination with alcohol. Do not drive or operate machinery until you know how Toralis affects you.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor. This will help you get the best results from your treatment and reduce the risk of side effects.
The recommended dose is one tablet per day.
Your doctor will determine the dose individually, depending on your clinical condition and other medicines you are taking. The response to treatment will be monitored based on blood pressure values and the results of some blood tests. Depending on the results, your doctor may recommend a higher or lower dose.
If you feel that the effect of Toralis is too strong or too weak, contact your doctor immediately.
In patients with kidney problems, your doctor may adjust the dose of Toralis depending on blood pressure values and the degree of kidney problems. If you are undergoing dialysis, it may be necessary to modify the daily dose of Toralis.
In patients with liver problems, your doctor may adjust the dose of Toralis depending on blood pressure values and the degree of liver problems.
Toralis is not recommended for use in children and adolescents.
Do not take more than the recommended dose. If you have taken too many Toralis tablets, contact your doctor immediately. Medical attention may be necessary.
The following symptoms may occur: dizziness due to excessive lowering of blood pressure, shortness of breath, rapid or slow heart rate, palpitations, feeling of anxiety, cough, stomach upset. You may urinate excessively, feel sleepy or confused.
If you miss a dose, take it as soon as possible, and take the next dose at the usual time. However, if it is almost time for the next dose, skip the missed dose. Do not take a double dose to make up for the missed tablet.
Stopping Toralis treatment may worsen your condition. Continue taking the medicine and attending follow-up appointments with your doctor, even if you feel well. Do not stop treatment unless your doctor tells you to.
If you have any further questions about taking this medicine, ask your doctor or pharmacist.
Like all medicines, Toralis can cause side effects, although not everybody gets them.
Toralis contains two active substances - lisinopril and torasemide, which you have previously taken in the form of separate tablets. Side effects related to each active substance may occur. Your doctor may recommend regular blood and/or urine tests to check if Toralis treatment has caused certain side effects.
Side effects reported for lisinopril and torasemide are listed below and may occur during Toralis treatment.
Common (may affect up to 1 in 10 people):dizziness (may be caused by too low blood pressure), worsening of metabolic alkalosis (symptoms include apathy, confusion, arrhythmias, seizures, breathing difficulties), decreased blood volume (symptoms include dizziness, excessive thirst, severe dryness of the mucous membranes, decreased urine output, dark urine, or constipation).
Uncommon (may affect up to 1 in 100 people):chest pain, inability to urinate in patients with urinary retention, circulatory disorders in the fingers and toes with a change in their color and pain (Raynaud's phenomenon).
Rare (may affect up to 1 in 1,000 people):excessive lowering of blood pressure, fainting, angioedema, significant decrease in urine output, syndrome of inappropriate antidiuretic hormone secretion (symptoms include weakness, muscle cramps, headaches, dark urine, or changes in urine volume, decreased appetite, excessive thirst, diarrhea, or constipation, nausea, or vomiting, low mood, confusion, or coma).
Very rare (may affect up to 1 in 10,000 people):severe skin reactions (toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema multiforme, cutaneous lymphoma), a syndrome of symptoms (several or all of the following symptoms: fever, muscle and joint pain, arthritis, rash, skin changes, also after exposure to light), myocardial infarction, or stroke, pancreatitis (symptoms include severe abdominal pain radiating to the back, with very poor general condition), acute abdominal pain with cramps, nausea, and vomiting (symptoms of angioedema of the intestines), liver function disorders, bronchospasm, bone marrow disorders, very low red blood cell count (symptoms include pale skin, dizziness, feeling of tiredness, shortness of breath, rapid heart rate, yellowing of the skin and eyes, dark urine), very low platelet count (symptoms include easy bruising, spontaneous bleeding, small red spots on the skin), very low white blood cell count (symptoms include weakness, fever, frequent infections).
Common (may affect up to 1 in 10 people):headache, feeling of tiredness, weakness, cough, diarrhea, stomach pain, nausea, vomiting, constipation, decreased appetite, muscle cramps, low potassium levels in the blood (due to torasemide), low sodium levels in the blood, increased uric acid, glucose, triglycerides, and cholesterol levels in the blood, or increased activity of certain liver enzymes in the blood.
Uncommon (may affect up to 1 in 100 people):high potassium levels in the blood (due to lisinopril), feeling of spinning, rapid or irregular heart rate, hallucinations, feeling of tingling, runny nose, dryness of the mucous membranes, impotence, increased urea or creatinine levels in the blood.
Rare (may affect up to 1 in 1,000 people):urinary tract infections; high urea levels in the blood; abnormal blood test results (decreased hemoglobin or hematocrit levels); low blood sugar levels in patients with diabetes treated with oral medicines or insulin, increased bilirubin levels in the blood, mood changes, confusion, decreased libido, depression, insomnia, excessive sleepiness, loss of appetite, taste disorders, indigestion, bloating, digestive disorders, changes in smell, blurred vision, flushing, rash, hives, itching, excessive sweating, hair loss, increased sensitivity to light, psoriasis, shortness of breath, lung infiltrates, laryngitis, bronchitis, nasal congestion, sore throat, back pain, joint pain, shoulder pain, gout.
Very rare (may affect up to 1 in 10,000 people):decreased or absent urine output, ringing in the ears, hearing loss, sinusitis, infection, or allergic inflammation of the lungs, lymph node enlargement, autoimmune disease; decreased platelet, red blood cell, or white blood cell count (leukocytes).
Lisinopril increases potassium levels in the blood, and thus may reduce potassium loss caused by torasemide.
If you experience any side effects, including any not listed in this leaflet, please tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
e-mail: ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the carton and blister. The expiry date refers to the last day of the month.
There are no special storage instructions for this medicine.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Toralis 10 mg+5 mg tablets:
White or almost white, round, biconvex tablets, smooth on both sides, with a diameter of 8.2 mm.
Toralis 10 mg+10 mg tablets:
White or almost white, round, biconvex tablets with the inscription "L10T10" on one side and smooth on the other side, with a diameter of 11.0 mm.
Toralis 20 mg+5 mg tablets:
White or almost white, round, biconvex tablets with a score, double inscription "LT" on one side and smooth on the other side, with a diameter of 11.0 mm.
Toralis 20 mg+10 mg tablets:
White or almost white, round, biconvex tablets with the inscription "L20T10" on one side and smooth on the other side, with a diameter of 11.0 mm.
Toralis 10 mg+5 mg tablets:
The medicine is available in packs containing 30, 60, or 90 tablets. One blister contains 15 tablets.
Toralis 10 mg+10 mg, 20 mg+5 mg, 20 mg+10 mg tablets:
The medicine is available in packs containing 30, 60, or 90 tablets. One blister contains 10 tablets.
Not all pack sizes may be marketed.
Aflofarm Farmacja Polska Sp. z o.o.
ul. Partyzancka 133/151
95-200 Pabianice
tel.: (42) 22-53-100
Aflofarm Farmacja Polska Sp. z o.o.
ul. Szkolna 31
95-054 Ksawerów
Czech Republic
Tolirasim
Lithuania
Tolirasim, 10mg/5mg, tablets, Tolirasim, 10mg/10mg, tablets, Tolirasim, 20mg/5mg, tablets, Tolirasim, 20mg/10mg, tablets
Poland
Toralis
Slovakia
Lisemid 10 mg/5 mg, Lisemid 10 mg/10 mg, Lisemid 20 mg/5 mg, Lisemid 20 mg/10 mg
Date of last revision of the leaflet:05/2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.